Factors contributing to institutionalization in patients with Huntington's disease

Movement Disorders

Volumn 26, Issue 9, 2011, Pages 1711-1716

  Rosenblatt, Adam ^a   Kumar, Brahma V ^a   Margolis, Russell L ^a   Welsh, Claire S ^a   Ross, Christopher A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Huntington's disease; Institutionalization; Progression

Indexed keywords

ADULT; ARTICLE; CAG REPEAT; COGNITIVE DEFECT; DISEASE DURATION; EDUCATION; FEMALE; FOLLOW UP; HUMAN; HUNTINGTON CHOREA; HUNTINGTON DISEASE ACTIVITIES OF DAILY LIVING SCALE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MOTOR IMPAIRMENT SCORE; PRIORITY JOURNAL; QUANTIFIED NEUROLOGIC EXAMINATION; RATING SCALE; SCORING SYSTEM;

ACTIVITIES OF DAILY LIVING; ADULT; DISABILITY EVALUATION; FEMALE; HUMANS; HUNTINGTON DISEASE; INSTITUTIONALIZATION; LONGITUDINAL STUDIES; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TRINUCLEOTIDE REPEATS;

EID: 79961208669     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23716     Document Type: Article

References (18)

1. Gusella JF, Wexler N, Conneally, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983; 306: 234-238.
2. Huntington Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971-983.
3. Nance MA, Sanders G. Characteristics of individuals with Huntington disease in long-term care. Mov Disord 1996; 11: 542-548.
4. Wheelock VL, Tempkin T, Marder K, et al. Predictors of nursing home placement in Huntington disease. Neurology 2003; 60: 998-1001.
5. Folstein SE, Jensen B, Leigh RJ, Folstein MF. The measurement of abnormal movement: methods developed for Huntington's disease. Neurobehav Toxicol Teratol 1983; 5: 605-609.
6. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
7. Bylsma FW, Rothlind J, Hall MR, Folstein SE, Brandt J. Assessment of adaptive functioning in Huntington's disease. Mov Disord 1993; 8: 183-190.
8. Hamilton N. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-61.
9. Rosenblatt A, Abbott MH, Gourley LM, et al. Predictors of neuropathological severity in 100 patients with Huntington's disease. Ann Neurol 2003; 54: 488-493.
10. Mahant N, McCusker EA, Byth K, Graham S; Huntington Study Group. Huntington's disease: clinical correlates of disability and progression. Neurology 2003; 61: 1085-1092.
11. Shoulson I, Fahn S. Huntington disease: clinical care and evaluation. Neurology 1979; 29: 1-3.
12. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996; 11: 136-142.
13. Ravina B, Romer M, Constantinescu R, et al. The relationship between CAG repeat length and clinical progression in Huntington's disease. Mov Disord 2008; 23: 1223-1227.
14. Gaugler JE, Duval S, Anderson KA, Kane RL. Predicting nursing home admission in the U.S: a meta-analysis. BMC Geriatr 2007; 7: 13.
15. Luppa M, Luck T, Weyerer S, Konig HH, Brahler E, Riedel-Heller SG. Prediction of institutionalization in the elderly. A systematic review. Age Ageing 2010; 39: 31-38.
16. Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990; 147: 1049-1051.
17. Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 2000; 48: 938-942.
18. Cohen CA, Gold DP, Shulman KI, Wortley JT, McDonald G, Wargon M. Factors determining the decision to institutionalize: a prospective study. Gerontologist 1993; 33: 714-720.